Endometrial Cancer Trial, Recruiting NCT06836869 Sponsor: Peking Union Medical College Hospital Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06836869
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between 18 and 65 years of age
  • People with a laboratory-confirmed diagnosis of cervical cancer, specifically squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma
  • People whose cervical cancer has been classified as FIGO 2018 stage IB2
  • People whose cervical tumour measures more than 2 cm but no larger than 4 cm, as measured by MRI (or by PET/CT, CT, or ultrasound if MRI is not suitable)
  • People for whom a specific type of radical hysterectomy (called a Type C or Q-M classification surgery) has been planned by their medical team
  • People with an ECOG performance status score of 0 or 1, meaning they are fully active or have only minor limitations in physical activity (confirm with trial site)
  • People who are willing to participate and sign a consent form
  • People who are able to attend follow-up appointments and complete required examinations
  • Women who have not yet gone through menopause and have a negative pregnancy test within 30 days before surgery
  • People whose blood and organ function tests meet the required levels set by the trial (confirm with trial site)

Who may not be able to join:

  • People whose cervical cancer is a less common type, such as gastric-type adenocarcinoma, neuroendocrine carcinoma, clear cell carcinoma, or carcinosarcoma
  • People whose scans suggest cancer has spread to lymph nodes in the pelvis or near the major abdominal blood vessels, or whose biopsy has confirmed lymph node involvement
  • People who have previously had radiation therapy to the pelvis or abdomen
  • People who have previously received chemotherapy given before surgery (neoadjuvant chemotherapy)
  • People whose uterus is larger than would be expected at 10 weeks of pregnancy
  • People who have medical conditions that make surgery or anaesthesia unsafe
  • People who are unable to be positioned lying tilted with their feet raised (called the Trendelenburg position) during surgery
  • People who are unable to cooperate with treatment or attend follow-up appointments
  • People who are currently pregnant
  • People who have had another type of cancer in the past, unless they have been cancer-free for more than 3 years with no current signs of the cancer returning

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8617810376318

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 February 2025
Est. completion
1 July 2032

Where this trial is recruiting

🇨🇳 China

Primary endpoints

4.5-year Disease-free Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov